Intrinsic Value of S&P & Nasdaq Contact Us

Stereotaxis, Inc. STXS AMEX

American Stock Excha • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
55/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.00
+97%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Stereotaxis, Inc. (STXS) has a negative trailing P/E of -8.6, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -11.65%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+97%).
  • Trailing Earnings Yield -11.65% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
  • Analyst consensus target $4.00 (+97% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 55/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
55/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
35/100
→ Income
~
GROWTH
40/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — STXS

Valuation Multiples
P/E (TTM)-8.6
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio9.92
P/S Ratio5.81
EV/EBITDA-8.9
Per Share Data
EPS (TTM)$-0.23
Book Value / Share$0.20
Revenue / Share$0.34
FCF / Share$-0.14
Yields & Fair Value
Earnings Yield-11.65%
Dividend Yield0.00%
Analyst Target$4.00 (+97%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -2.7 0.09 -0.91 0.44 -
2017 -3.1 -0.37 -0.88 0.58 -
2018 482.2 -4.78 7.74 1.92 -
2019 -72.6 0.02 11.69 11.54 -
2020 -55.7 -0.87 9.20 13.90 -
2021 -43.7 -0.96 11.88 13.38 -
2022 -8.6 -0.14 4.93 5.59 -
2023 -6.8 -1.77 6.44 5.28 -
2024 -8.1 -0.73 16.99 7.22 -
2025 -9.7 0.58 11.17 6.46 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-0.24 $32.16M $-5.29M -16.4%
2017 $-0.26 $31.14M $-5.89M -18.9%
2018 $0.00 $29.35M $116.76K 0.4%
2019 $-0.07 $28.9M $-4.23M -14.6%
2020 $-0.11 $26.63M $-6.65M -25%
2021 $-0.11 $35.02M $-8.44M -24.1%
2022 $-0.26 $28.15M $-18.29M -65%
2023 $-0.27 $26.77M $-20.71M -77.4%
2024 $-0.30 $26.92M $-24.05M -89.3%
2025 $-0.25 $32.38M $-21.64M -66.8%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.19 $-0.22 – $-0.15 $41.1M $40.85M – $41.35M 3
2027 $-0.13 $-0.20 – $-0.06 $53.5M $48.96M – $58.04M 3
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message